Serum level of mast cell tryptase in patients with oral squamous cell carcinoma: Lack of correlation with clinicopathologic factors

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 2955-2958

  Jaafari Ashkavandi, Zohreh ^a   Khademi, Bijan ^b   Akbari, Somayeh ^c   Malekzadeh, Mahyar ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Head and neck; Mast cell; Oral; Serum; Squamous cell carcinoma; Tryptase

Indexed keywords

TRYPTASE; TUMOR MARKER;

BLOOD; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; HUMAN; MALE; MAST CELL; METABOLISM; METASTASIS; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MAST CELLS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; TRYPTASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84880385439     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.2955     Document Type: Article

References (28)

1. Artuc M, Steckelings M, Henz BM (2002). Mast cell-fibroblast interactions: human mast cells as source and inducer of fibroblast and epithelial growth factors. J Invest Dermatol, 118, 391-5.
2. Cheema VS, Ramesh V, Balamurali PD (2012). The relevance of mast cells in oral squamous cell carcinoma. J Clin Diagn Res, 6, 1803-7.
3. Ch'ng S, Wallis RA, Yuan L, Davis PF, Tan ST (2006). Mast cells and cutaneous malignancies. Mod Pathol, 19, 149-59.
4. Coussens LM, Raymond WW, Bergers G, et al (1999). Inflammatory mast cells up- regulates angiogenesis during squamous epithelial carcinogenesis. Genes Dev, 13, 1382-97.
5. Elpek G, Gelen T (2001). The prognostic relevance of angiogenesis and mast cells in SCC of the esophagus. J Clin Pathol, 54, 940-4.
6. Fukushima H, Ohsawa M, Ikura Y, et al (2006). Mast cells in diffuse large B-cell lymphoma; their role in fibrosis. Histopathology, 49, 498-505.
7. Galli SJ, KalesnikoffJ, Grimbaldeston MA, et al (2005). Mast cells as "tunable" effector and immunoregulatory cells: Recent advances. Annu Rev Immunol, 23, 749-86.
8. Galli SJ, Nakae S, Tsai M (2005). Mast cells in the development of adaptive immune responses. Nat Immunol, 6, 135-42.
9. Hogan AD, Schwartz LB (1997). Markers of mast cell degranulation. Method, 13, 43-52.
10. Iamaroon A, Surawut P, Sumana J (2003). Increase of mast cell and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med, 32, 195-9.
11. Jaafari-Ashkavandi Z, Moshref M, Mashhadi-Abbas F, Sargolzaie S, Taghavi N (2010). Evaluation of CD31 expression and mast cell count in dysplastic lesions and squamous cell carcinoma of the oral cavity. Iran Red Crescent Med J, 12, 272-6
12. Messadi DV, Wilder-Smith P, Wolinsky L (2009). Improving oral cancer survival: the role of dental providers. J Calif Dent Assoc, 37, 789-98.
13. Nechushtan H (2010). The complexity of the complicity of mast cells in cancer. Int J Biochem Cell Biol, 42, 551-4
14. Norrby K (2002). Mast cell and angiogenesis. APMIS, 110, 355-71.
15. Oliveira-Neto HH, Leite AF, Costa NL, et al (2007). Decrease in mast cells in oral squamous cell carcinoma: possible failure in the migration of these cells. Oral Oncol, 43, 484-90.
16. Rajput AB, Turbin DA, Cheang MC, et al (2008). Stromal mast cells in invasive breast cancer are a marker of favorable prognosis: a study of 4,444 cases. Breast Cancer Res Treat, 107, 249-57.
17. Ribatti D, Crivellato E (2009). The controversial role of mast cells in tumor growth. Int Rev Cell Mol Biol, 275, 89-131.
18. Ribatti D, Ennas MG, Vacca A, et al (2003). Tumor vascularity and tryptase positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest, 33, 420-5.
19. Rojas IG, Spencer ML, Martinez SL, et al (2005). Characterization of mast cells subpopulation in lip cancer. J Oral Path Med, 34, 268-273.
20. RuëffF, Przybilla B, Biló MB, et al (2010). Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase. J Allergy Clin Immunol, 126, 105-11.
21. Samoszuk M, Corwin MA (2003). Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer. Int J Cancer, 107, 159-63.
22. Sayed BA, Christy A, Quirion MR, Brown MA (2008). The master switch: The role of mast cells in autoimmunity and tolerance. Annu Rev Immunol, 26, 705-39.
23. Sperr WR, Jordan JH, Baghestanian M, et al (2001). Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood, 98, 2200-9.
24. Strouch MJ, Cheon EC, Salabat MR, et al (2010). Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin Cancer Res, 16, 2257-65.
25. Tayebi-Meybodi N, Javidi Z, Esmaili HA, Nahidi Y (2007). Mast cells and histopathologic variants of basal cell carcinoma. Iran J Dermatol, 10, 135-41.
26. Tinge B, Molin D, Bergqvist M, Ekman S, Bergström S (2010). Mast cells in squamous cell esophageal carcinoma and clinical parameters. Cancer Genomics Proteomics, 7, 25-9.
27. Valent P, Horny HP, Triggiani M, Arock M (2011). Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria. Int Arch Allergy Immunol, 156, 119-27.
28. Xiang M, Gu Y, Zhao F, et al (2020). Mast cell tryptase promotes breast cancer migration and invasion. Oncol Rep, 23, 615-9.